Eisai Co. Ltd.'s Fiscal Year is From April To March.
The item "Total-Debt-To-Ebitda" stands at 2.18 as of 09/30/2025, the highest value since 03/31/2023.
As of the end of Eisai Co. Ltd.'s second quarter, the item "Total Debt To Ebitda" stands at 2.18. This represents an increase of 68.00 percent compared to it's value at the end of it's first quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 17.22 percent compared to the value the year prior.
The 1 year change in percent is 17.22.
The 3 year change in percent is -4.07.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Total Debt To Ebitda | 905,699,262,464.00 |
![]() | Johnson & Johnson - Total Debt To Ebitda | 486,508,953,600.00 |
![]() | AbbVie Inc - Total Debt To Ebitda | 399,570,305,024.00 |
![]() | Roche Holding AG - Total Debt To Ebitda | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Total Debt To Ebitda | 280,205,508,085.11 |